Found: 3
Select item for more details and to access through your institution.
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 635, p. 1, doi. 10.1126/scitranslmed.abl8124
- By:
- Publication type:
- Article
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 753, p. 1, doi. 10.1126/scitranslmed.ado2817
- By:
- Publication type:
- Article
Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897.
- Published in:
- 2018
- By:
- Publication type:
- journal article